Drug Trial Radar · NCT06742957
Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Dec 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
560
Actual
Start
Dec 17, 2024
Primary completion
Oct 7, 2025
Study completion Nov 12, 2025
Sponsor
- Lead sponsor
- Teva Pharmaceuticals USATeva (TEVA)
- Sponsor type
- Industry
- Collaborators
- Teva Pharmaceuticals, Inc.
- First posted
- Dec 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To compare the safety and efficacy of the test (Tapinarof Cream 1%), placebo (vehicle cream) and reference VTAMA® (Tapinarof Cream 1%) treatments to demonstrate clinical equivalence in patients with plaque psoriasis.
Conditions
- Plaque Type Psorisis
Interventions
Tapinarof Cream 1%Drug
Cream
VTAMA®Drug
Cream
PlaceboDrug
Cream
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary change in the Physician Global Assessment (PGA)Time frame: 12 Weeks
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Site 12107
Scottsdale, Arizona
Site 12101
Bryant, Arkansas
Site 12110
Dublin, California
Site 12112
Dublin, California
Site 12102
Fremont, California
Site 12119
Huntington Beach, California
Site 12120
Northridge, California
Site 12111
Pomona, California
Site 12122
Greenwich, Connecticut
Site 12115
Fort Lauderdale, Florida
Site 12104
Miami, Florida
Site 12116
Miami, Florida
Site 12113
Miami, Florida
Site 12114
Miramar, Florida
Site 12108
Chicago, Illinois
Site 12121
Rolling Meadows, Illinois
Site 12106
Clarksville, Indiana
Site 12123
Merrillville, Indiana
Site 12105
Louisville, Kentucky
Site 12109
Las Vegas, Nevada
12127
Woodbury, New York
Site 12126
Portland, Oregon
Site 12125
Upper Saint Clair, Pennsylvania
Site 12103
College Station, Texas
Site 12118
El Paso, Texas
Site 12117
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.